Phospholipid synthesis enzymes

Phospholipid synthesis enzymes represent a broad functional class of proteins responsible for the de novo synthesis and remodeling of phospholipids, which serve as the primary structural components of all cellular membranes (Vance & Vance, 2008). This group includes key enzymes such as choline kinase, CTP:phosphocholine cytidylyltransferase, and various acyltransferases that operate within the Kennedy pathway and the Lands' cycle (Glunde et al., 2011, Nature Reviews Cancer). These enzymes are essential for maintaining membrane integrity, facilitating vesicular transport, and generating lipid-derived signaling molecules like diacylglycerol and phosphatidic acid (Ridgway & McLeod, 2015). In many diseases, particularly cancer, these enzymes are significantly upregulated to support the high demand for membrane biogenesis required for rapid cell proliferation (mBio, 2017). Therapeutic targeting of specific enzymes within this class, such as choline kinase alpha, aims to disrupt membrane assembly and oncogenic signaling to induce cell death (PubMed: 21863051). Additionally, these enzymes are targets for anti-infective agents, as seen with the use of miltefosine to inhibit phospholipid synthesis in parasites (PubChem). However, because these enzymes are fundamental to normal cellular physiology, achieving selective toxicity remains a major challenge in drug development (Nature Reviews Cancer, 2011).

Other names

Phospholipid biosynthetic enzymesGlycerophospholipid synthesis enzymesLipid biosynthetic enzymes

Inhibition of rate-limiting enzymes in phospholipid biosynthetic pathways, such as the Kennedy pathway, to deplete essential membrane components and signaling precursors.